Carmell Corp - Ordinary Shares - Class A
CTCX
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.94M
Close$
$0.07
64.3% downside
Current Fair Value
64.3% downsideOvervalued by 64.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.94 Million |
|---|---|
| Enterprise Value | $5.91 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.83 |
| Beta | 0.51 |
| Outstanding Shares | 1,899,910 |
Return
| Return on Equity | 99.07% |
|---|---|
| Return on Assets | -415.93% |
| Return on Invested Capital | 99.44% |
Valuation & Multiples
| P/E Ratio | -0.08 |
|---|---|
| PEG | 1.69 |
| Price to Sales | - |
| Price to Book Ratio | -0.05 |
| Enterprise Value to Revenue | 3.3 |
| Enterprise Value to EBIT | -0.89 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | -0.04 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Carmell Therapeutics Corp
5 employeesalpcot agro is a swedish limited liability company and was incorporated in 2006. the company’s objective is to generate an attractive total return on invested capital by acquiring and farming agricultural land in russia and in other cis member states.